# Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication

> **NCT07255378** · — · RECRUITING · sponsor: **Jamil Cedeño Mora** · enrollment: 1200 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Usage of vasopressin (VAP) as a second-line vasopressor in septic shock patients.

## Key facts

- **NCT ID:** NCT07255378
- **Lead sponsor:** Jamil Cedeño Mora
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-10-31
- **Final completion:** 2028-01-01
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2025-12-15

## Collaborators

- Fundación para la Investigación Biomédica del Hospital Gregorio Maranon
- Hospital General Universitario Gregorio Marañon

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07255378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07255378, "Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07255378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*